Illumina Inc. (ILMN): 2024 Company Profile, Product Pipeline Analysis, and Ongoing Clinical Trials Insights
June 10, 2024 07:42 ET
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Illumina Inc (ILMN) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering.This report is a...
Virtu Financial, Inc. Announces Proposed Opportunistic Private Offering of $500 Million of Senior First Lien Notes Due 2031
June 10, 2024 07:39 ET
|
Virtu Financial, LLC
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq: VIRT) (“Virtu”) announced today that its subsidiaries, VFH Parent LLC (the “Issuer”) and Valor Co-Issuer, Inc. (the...
Thesis Gold Announces $20 Million Private Placement
June 10, 2024 07:35 ET
|
Thesis Gold Inc.
Thesis Gold Announces $20 Million Private Placement
Inotiv, Inc. Provides Business Updates
June 10, 2024 07:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
AYR Wellness Secures Real Estate Financing for Florida Indoor Cultivation
June 10, 2024 07:30 ET
|
Ayr Wellness Inc.
MIAMI, June 10, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today...
Monster Beverage Corporation Announces Final Results of Tender Offer
June 10, 2024 07:30 ET
|
Monster Beverage Corporation
CORONA, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (“Monster”) (NASDAQ: MNST) announced today the final results of its modified “Dutch auction” tender offer, which...
FuelCell Energy Reports Second Quarter of Fiscal 2024 Results
June 10, 2024 07:30 ET
|
FuelCell Energy, Inc.
Second Quarter Fiscal 2024 Summary(All comparisons are year-over-year unless otherwise noted) Revenue of $22.4 million, compared to $38.3 millionGross loss of $(7.1) million compared...
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
June 10, 2024 07:30 ET
|
Shattuck Labs, Inc.
AUSTIN, TX and DURHAM, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion...
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
June 10, 2024 07:30 ET
|
Pyxis Oncology
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers,...
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
June 10, 2024 07:30 ET
|
Revive Therapeutics Ltd.
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...